跳至主要内容
临床试验/NCT03352232
NCT03352232已完成早期 1 期

Oxygenating the Potential: Hyperbaric Oxygen and Manipulative Therapies to Regain Function in Stroke Survivors

Abington Memorial Hospital2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2018年2月3日最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
5
试验地点
2
主要终点
National Institute of Health Stroke Score (NIHSS) 0-5 or Modified Rankin Score (mRS) 0-2

研究概览

简要总结

To study safety, feasibility and outcomes of combining osteopathic manipulative therapies with hyperbaric oxygen therapy in reducing the functional deficits in stroke survivors in subacute and chronic phases post ischemic stroke. To document the same as part of a pilot project in anticipation of further investigational studies.

详细描述

The primary objective of this study is to show that hyperbaric oxygen therapy combined with osteopathic manipulative therapies improve outcomes in patients who have persistent neurological deficits after ischemic stroke compared to historical norms.

The secondary objectives of this study is to demonstrate safety and feasibility of treating patients post stroke with hyperbaric oxygen and osteopathic therapies as well as determine improvements in multiple assessment scales of motor function, depression, activities of daily living(ADL) and pain

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Post Ischemic stroke
  • Patients aged 18-80
  • mRS>/=3, which connotes moderate disability requiring some help.
  • Persistent significant motor dysfunction of at least one arm
  • Subacute stroke patients (within three months from time of stroke)
  • Chronic stroke patients (more than 6months from time of stroke)
  • Patient must be able to understand instructions and verbalize discomfort
  • Reliable attendance for daily (M-F) HBOT treatment and 2x/week OMT sessions for up to 6weeks

排除标准

  • Hemorrhagic stroke
  • Prior functional disability mRS >1
  • Expressive or receptive aphasia
  • Bedbound patients due to lifting limitations for HBOT
  • History of severe, advanced emphysema with bullous disease
  • Prior history of spontaneous pneumothorax or chest surgery
  • Prior history of depression requiring medications
  • Concomitant non-conventional rehab therapies including: acupuncture, botulinum toxin injections, massage therapy
  • Significant claustrophobia

结局指标

主要结局

National Institute of Health Stroke Score (NIHSS) 0-5 or Modified Rankin Score (mRS) 0-2

时间窗: 90 Days

Primary Outcome NIHSS 0-5, 0 without deficits; mRS 0-2, 0 without disability - 2 slight disability, no need for assistance

次要结局

  • Beck Depression Inventory(90 days)
  • Wolf Motor Score(90 days)
  • Functional Independence Measure (FIM)(90 days)
  • Rivermead Extended Activities of Daily Living (EADL) scale(90 days)
  • Medical Outcomes 36 Item(90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hana Choe

Assistant Director NeuroIntervention and Neurocritical Care

Abington Memorial Hospital

研究点 (2)

Loading locations...

相似试验